108927 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7); Nucleotidyltransferases (2.7.7) RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
SELF-REPLICATING RNA AND USE THEREOF
#2PSEUDOMONAS RECOMBINANT PROTEIN EXPRESSION SYSTEM
#3METHODS AND COMPOSITIONS FOR PRODUCING SELF-AMPLIFYING RNA FOR GENE SILENCING IN PLANTS
#4METHODS TO INCREASE IMMUNOGENICITY OF RDRP
#5Replicon Compositions and Methods of Using Same for the Treatment of Diseases
#6Methods for Suppression of Gene Silencing in Plants
#7RECOMBINANT VECTOR AND USES THEREOF
#8Viral Vaccines
#9METHODS AND COMPOSITIONS FOR PRIME EDITING RNA
#10RNA POLYMERASE VARIANTS
#11RNA-ONLY DERIVED ORTHOMYXOVIRUSES AND ASSOCIATED VECTORS AND USES THEREOF
#12EUKARYOTIC CELL LYSATES COMPRISING EXOGENOUS ENZYMES AND METHODS FOR PREPARING THE SAME
#13METHODS, KITS, AND APPROACHES FOR VIRAL VACCINES
#14COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN BINDING PROTEINS
#15ENZYME-PORE CONSTRUCTS
#16LIMITED SELF-REPLICATING MRNA MOLECULAR SYSTEM, PRODUCING METHOD AND USE
#17CIS-REPLICON CONSTRUCT
#18RECOMBINANT PROTEINS WITH INCREASED SOLUBILITY AND STABILITY
#19Novel Replicase Cycling Reaction (RCR) and the Related SamRNA Designs Thereof
#20Nucleic acid-based membrane constructs for RNA polymerase detection
#21Novel Replicase Cycling Reaction (RCR)
#22CELL-FREE PRODUCTION OF RIBONUCLEIC ACID
#23Novel RNA Composition and Production Method for Use in iPS Cell Generation
#24Xylose-induced genetically engineered bacteria used for producing ectoine and use thereof
#25Enzyme-pore constructs
#26SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
#27GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA
#28Size selection of RNA using poly(A) polymerase
#29Copy number variant leading to virus resistance
#30Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#31Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#32COMPOSITIONS AND METHODS COMPRISING VIRAL REVERSE TRANSCRIPTASE
#33Borna viral vector and use thereof
#34Size selection of RNA using poly(A) polymerase
#35Substituted nucleosides, nucleotides and analogs thereof
#36Generation of human iPS cells by a synthetic self-replicative RNA
#37Viral Polypeptide Fragments That Bind Cellular POL II C-Terminal Domain (CTD) and Their Uses
#38Retrovirus packaging cell
#39Enzyme-pore constructs
#40Copy number variant leading to virus resistance
#41Attenuated influenza vaccines and uses thereof
#42Generation of human iPS cells by a synthetic self-replicative RNA
#43Cell-free production of ribonucleic acid
#44POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE
#45Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#46ENZYME-PORE CONSTRUCTS
#47Coronavirus
#48Modified gene conferring virus resistance
#49Synthetic genes and genetic constructs
#50Increasing the expression of a transgene in eukaryotic cells by reducing RNA interference
#51Substituted nucleosides, nucleotides and analogs thereof
#52Compositions, methods and kits for real-time nucleic acid analysis in live cells
#53Attenuated influenza vaccines and uses thereof
#54Induction of cross-reactive cellular response against rhinovirus antigens
#55Enzyme-pore constructs
#56Substituted nucleosides, nucleotides and analogs thereof
#57Generation of human iPS cells by a synthetic self-replicative RNA
#58Polypeptide fragments comprising endonuclease activity and their use
#59CRYSTAL STRUCTURE OF HCV POLYMERASE COMPLEXES AND METHODS OF USE
#60PCR reaction mixtures with decreased non-specific activity
#61Enzyme-pore constructs
#62Control of gene expression
#63Compositions and methods for the protection of nucleophilic groups
#64Synthetic genes and genetic constructs
#65Modified T7-related RNA polymerases and methods of use thereof
#66Crystal structure of amino terminal portion of influenza virus polymerase PA subunit and use thereof
#67CONTROL OF GENE EXPRESSION
#68PCR reaction mixtures with decreased non-specific activity
#69Synthetic genes and genetic constructs
#70Polypeptide Fragments Comprising Endonuclease Activity and Their Use
#71Construction and crystallization of expression system for RNA polymerase PB1-PB2 protein derived from influenza virus
#72MAMMALIAN RNA DEPENDENT RNA POLYMERASE
#73ENZYME-PORE CONSTRUCTS
#74Dengue chimeric viruses
#75Compositions and methods for the protection of nucleophilic groups
#76MICROCAPSULES AND METHODS OF USE FOR AMPLIFICATION AND SEQUENCING
#77Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
#78RNA polymerase derived from influenza virus
#79MUTATIONS IN THE NS5B PROTEIN OF THE HCV
#80ACTIVE TRUNCATED FORM OF THE RNA POLYMERASE OF FLAVIVIRUS
#81Dengue chimeric viruses
#82METHOD OF DRUG DESIGN
#83VECTORS AND METHODS FOR ENZYME PRODUCTION
#84Methods of detecting transcription
#85Microcapsules and methods of use for amplification and sequencing
#86Active truncated form of the RNA polymerase of
#87Plant RNA transport and RNA-directed RNA polymerase proteins
#88HCV RNA-dependent RNA polymerase
#89RNA-Dependent RNA Polymerase, Methods And Kits For The Amplification And/Or Labelling Of RNA
#90Modified vectors for organelle transfection
#91HCV RNA-dependent RNA polymerase
#92Engineering broad spectrum virus disease resistance in plants based on the regulation of expression of the RNA dependant RNA polymerase 6 gene
#93Continuous in-vitro evolution
#94HCV polymerase suitable for crystal structure analysis and method for using the enzyme
#95ES cells having enhanced RNAi effect
#96Compositions of coronaviruses with a recombination-resistant genome
#97Soluble rna polymerase protein and methods for the use thereof
#98Plant RNA transport and RNA-directed RNA polymerase proteins
#99Inducible alphaviral gene expression system
#100Recombinant negative strand RNA virus expression system and vacccines
#101Control of gene expression
#102Control of gene expression
#103RNA-dependent RNA polymerase functioning preferably on a RNA matrix and promoter-dependent transcription process with said RNA-dependent RNA polymerase
#104Grapevine leafroll virus proteins and their uses
#105Active truncated form of the RNA polymerase of flavivirus
#106Recombinant negative strand RNA virus expression systems and vaccines
#107ES cells having enhanced RNAi effect
#108Hepatitis C Virus NS5B polymerase inhibitor binding pocket
#109Conserved region T cell vaccines for coronavirus and methods of use
#110Conserved region T cell vaccines for coronavirus and methods of use